PUBLISHER: TechNavio | PRODUCT CODE: 1792232
PUBLISHER: TechNavio | PRODUCT CODE: 1792232
The AI in epidemiology market is forecasted to grow by USD 956.6 mn during 2024-2029, accelerating at a CAGR of 25.7% during the forecast period. The report on the AI in epidemiology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of big data and imperative for advanced analytical capabilities, intensifying demand for predictive modeling and real-time outbreak surveillance, and accelerated advancements in AI algorithms and computational infrastructure.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 24.5% |
CAGR | 25.7% |
Incremental Value | $956.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's AI in epidemiology market is segmented as below:
By Deployment
By Application
By End-user
By Geographical Landscape
This study identifies the confluence of big data and advanced computational power as one of the prime reasons driving the AI in epidemiology market growth during the next few years. Also, imperative for predictive surveillance amidst escalating global health threats and surging strategic investments and cross-sector collaborations will lead to sizable demand in the market.
The report on the AI in epidemiology market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading AI in epidemiology market vendors that include AIME Healthcare, Alphabet Inc., Bayer AG, Cardiolyse, Cerner Corp., Cognizant Technology Solutions Corp., eClinicalWorks LLC, Epic Systems Corp., Intel Corp., Komodo Health Inc., Medical Information Technology Inc., Microsoft Corp., Orion Health, Predixion Software, Saama Technologies Inc., SAS Institute Inc., and Siemens Healthineers AG. Also, the AI in epidemiology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: